This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lagranderie, M. Articles by Leclerc, C. Search for Related Content PubMed PubMed Citation Articles by Lagranderie, M. Articles by Leclerc, C.

 Previous Article  |  Next Article 

Infect. Immun., Aug 1997, 3057-3064, Vol 65, No. 8
Copyright © 1997, American Society for Microbiology

Genetic control of antibody responses induced by recombinant Mycobacterium bovis BCG expressing a foreign antigen

M Lagranderie, R Lo-Man, E Deriaud, B Gicquel, M Gheorghiu and C Leclerc
Laboratoire du BCG, Institut Pasteur, Paris, France.

Recombinant Mycobacterium bovis BCG expressing foreign antigens represents a promising candidate for the development of future vaccines and was shown in several experimental models to induce protective immunity against bacterial or parasitic infections. Innate resistance to BCG infection is under genetic control and could modify the immune responses induced against an antigen delivered by such engineered microorganisms. To investigate this question, we analyzed the immune responses of various inbred strains of mice to recombinant BCG expressing beta-galactosidase. These experiments demonstrated that BALB/c mice developed strong antibody responses against BCG expressing beta-galactosidase under the control of two different promoters. In contrast, C57BL/6, C3H, and CBA mice produced high anti-beta- galactosidase antibody titers only when immunized with recombinant BCG expressing beta-galactosidase under the control of the pblaF* promoter, which induced the production of high levels of this antigen. This difference in mouse responsiveness to recombinant BCG was not due to innate resistance to BCG infection, since similar immune responses were induced in Ity(r) and Ity(s) congenic strains of mice. In contrast, the analysis of anti-beta-galactosidase antibody responses of H-2 congenic mice in two different genetic backgrounds demonstrated that H-2 genes are involved in the immune responsiveness to beta-galactosidase delivered by recombinant BCG. Together, these results demonstrate that immune responses to an antigen delivered by recombinant BCG are under complex genetic influences which could play a crucial role in the efficiency of future recombinant BCG vaccines.

This article has been cited by other articles:

• Varaldo, P. B., Leite, L. C. C., Dias, W. O., Miyaji, E. N., Torres, F. I. G., Gebara, V. C., Armoa, G. R. G., Campos, A. S., Matos, D. C. S., Winter, N., Gicquel, B., Vilar, M. M., McFadden, J., Almeida, M. S., Tendler, M., McIntosh, D. (2004). Recombinant Mycobacterium bovis BCG Expressing the Sm14 Antigen of Schistosoma mansoni Protects Mice from Cercarial Challenge. Infect. Immun. 72: 3336-3343 [Abstract] [Full Text]